ASX (AUD): Fisher & Paykel Healthcare Corporation Limited (FPH)
Last Price
35.66
Today's Change
+0.90 (2.58%)
Day's Change
34.60 - 35.66
Trading Volume
348,045
Market Cap
20 Billion
Shares Outstanding
586 Million
Avg Volume
370,201
Avg Price (50 Days)
30.47
Avg Price (200 Days)
25.77
PE Ratio
169.81
EPS
0.21
Earnings Announcement
26-Nov-2024
Previous Close
34.76
Open
34.68
Day's Range
34.6 - 35.66
Year Range
18.58 - 35.66
Trading Volume
348,045
1 Day Change
2.59%
5 Day Change
4.15%
1 Month Change
19.07%
3 Month Change
28.50%
6 Month Change
56.75%
Ytd Change
61.72%
1 Year Change
81.38%
3 Year Change
13.28%
5 Year Change
130.96%
10 Year Change
660.34%
Max Change
1367.49%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.